Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab
Golay, Josée, Da Roit, Fabio, Bologna, Luca, Ferrara, Claudia, Leusen, Jeanette H., Rambaldi, Alessandro, Klein, Christian, Introna, Martino
Published in Blood (14.11.2013)
Published in Blood (14.11.2013)
Get full text
Journal Article
Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation
Golay, Josée, Valgardsdottir, Rut, Musaraj, Gerta, Giupponi, Damiano, Spinelli, Orietta, Introna, Martino
Published in Blood (28.03.2019)
Published in Blood (28.03.2019)
Get full text
Journal Article
Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
Pievani, Alice, Borleri, Gianmaria, Pende, Daniela, Moretta, Lorenzo, Rambaldi, Alessandro, Golay, Josée, Introna, Martino
Published in Blood (22.09.2011)
Published in Blood (22.09.2011)
Get full text
Journal Article
Ofatumumab is more efficient than rituximab in lysing B chronic lymphocytic leukemia cells in whole blood and in combination with chemotherapy
Bologna, Luca, Gotti, Elisa, Da Roit, Fabio, Intermesoli, Tamara, Rambaldi, Alessandro, Introna, Martino, Golay, Josée
Published in The Journal of immunology (1950) (01.01.2013)
Published in The Journal of immunology (1950) (01.01.2013)
Get full text
Journal Article
Mechanism of action of type II, glycoengineered, anti-CD20 monoclonal antibody GA101 in B-chronic lymphocytic leukemia whole blood assays in comparison with rituximab and alemtuzumab
Bologna, Luca, Gotti, Elisa, Manganini, Massimiliano, Rambaldi, Alessandro, Intermesoli, Tamara, Introna, Martino, Golay, Josée
Published in The Journal of immunology (1950) (15.03.2011)
Published in The Journal of immunology (1950) (15.03.2011)
Get full text
Journal Article
M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro
Leidi, Marzia, Gotti, Elisa, Bologna, Luca, Miranda, Elena, Rimoldi, Monica, Sica, Antonio, Roncalli, Massimo, Palumbo, Giuseppe A, Introna, Martino, Golay, Josee
Published in The Journal of immunology (1950) (01.04.2009)
Published in The Journal of immunology (1950) (01.04.2009)
Get full text
Journal Article
Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy
Da Roit, Fabio, Engelberts, Patrick J, Taylor, Ronald P, Breij, Esther C W, Gritti, Giuseppe, Rambaldi, Alessandro, Introna, Martino, Parren, Paul W H I, Beurskens, Frank J, Golay, Josée
Published in Haematologica (Roma) (01.01.2015)
Published in Haematologica (Roma) (01.01.2015)
Get full text
Journal Article
Genetic defects of gamma‐secretase genes in a multiple myeloma patient with high and dysregulated BCMA surface density: A case report
Cattaneo, Irene, Valgardsdottir, Rut, Cavagna, Roberta, Spinelli, Orietta, Bartoletti‐Stella, Anna, Capellari, Sabina, Galli, Monica, Golay, Josée
Published in British journal of haematology (01.02.2024)
Published in British journal of haematology (01.02.2024)
Get full text
Journal Article
Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo
Di Gaetano, Nicola, Cittera, Elena, Nota, Rachele, Vecchi, Annunciata, Grieco, Valeria, Scanziani, Eugenio, Botto, Marina, Introna, Martino, Golay, Josee
Published in The Journal of immunology (1950) (01.08.2003)
Published in The Journal of immunology (1950) (01.08.2003)
Get full text
Journal Article
From the bench to the bedside: ways to improve rituximab efficacy
Cartron, Guillaume, Watier, Hervé, Golay, Josée, Solal-Celigny, Philippe
Published in Blood (01.11.2004)
Published in Blood (01.11.2004)
Get full text
Journal Article